If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 20.50
Bid: 20.00
Ask: 21.00
Change: -0.25 (-1.20%)
Spread: 1.00 (5.00%)
Open: 20.75
High: 20.75
Low: 20.50
Prev. Close: 20.75
IOF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Iodine Production Update

3 Jun 2014 07:00

RNS Number : 6499I
Iofina PLC
03 June 2014
 



3 June 2014

 

Iofina plc

("Iofina" or the "Company")

(LSE AIM: IOF)

 

Iodine Production Update 

 

Iofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, are pleased to update the market today on continued progress and production during the month of May (or "the Period").

 

The Company produced 40.5 metric tons (mt) of crystallised iodine at Iofina Resources in the Period, compared with 21.8 mt in April, an increase of 86% month on month. This improved production rate exceeds the Company's production target for the month. The Company was also profitable for the Period in terms of both EBITDA and net profit, following the implementation of operational efficiencies and cost controls put in place after the recent board and management changes.

 

IO#1 Production Plant

IO#1 had record monthly production, with the plant continuing to run at record capacity, with little to no downtime. IO#1 continues to make cost-improvements with chemicals and supplies. Early this month, IO#1 will be subjected to a test that could potentially eliminate a certain chemical, resulting in additional savings. If successfully tested, the elimination of this chemical could result in savings of circa $4,000 a day through IO#1-IO#6 when combined.

 

IO#2 Production Plant

IO#2 achieved record monthly production, with the Company still seeing more optimisation potential in the coming months. Controllable run-time at the plant was excellent and should remain so with recent site upgrades which can fully bypass the Operators salt water disposal (SWD) tanks when they are down for maintenance or experience high-tank levels and go directly to the the SWD injection well. IO#2 received the greatest benefits from recent cost controls throughout the supply chain in the period.

 

IO#3 Production Plant

IO#3 had another record monthly production rate, despite its limited brine due to the producer's fracking schedule.IO#3's plant performance and run-time, excluding lower brine flows, is as expected. Also as expected, June appears to be an intensive month for fracking near the IO#3 plant. Iofina will continue to monitor and adjust costs and labor accordingly during these events.

 

IO#4 Production Plant

IO#4 had a record month but did not meet the Company's targets. Minor issues were addressed and performance is on track to meet June 2014 production. The issues were a result of debris still being contained within the system which needed to be removed and cleaned. We see consistent brine capacity at the site even during fracking which is encouraging. The Company is moving forward on improvements to allow greater volumes of brine to IO#4 which currently is maximized at 20,000 barrels per day.

 

IO#5 Production Plant

IO#5 remained idle as the plant awaits connection to the power grid. Hard power is expected in the next 30 days. Once wired into the power grid, production at IO#5 will restart.

 

IO#6 Production Plant

IO#6 construction continues to progress with completion expected near month end. The improvements being made to IO#4 are being reflected in the design of IO#6 to ensure maximum brine supply. The commissioning time line is expected to be unchanged and, as previously guided, IO#6 is expected to be operational around the end of Q2.

 

The Company's focus to reduce supply chain operational expenditure through all areas of operation is being reflected in considerable savings on a daily basis. While these reductions have been significant, work is still ongoing to fully realise a smooth supply chain management resulting in lower production cash cost. The Company's May production cost remains favorable amongst iodine producers.

Commenting on today's announcement, Lance Baller, Non-executive Chairman and Co-founder stated: "We are very pleased to have exceeded this month's targeted production, with an 86 per cent increase over last months' production. The dedication and focus of Iofina's employees continues to demonstrate the quality of the Company's strong assets and technology. We still have much to accomplish in the coming months but already are starting to make progress. We have started a rotating preventative maintenance program for all IOSorb® plants and cost-controls for capital projects, chemicals, labour, supplies, and utilities through means of a new Purchase Order system. We are looking forward to continued operational improvement and the addition of production from IO#5 and IO#6 in coming months."

"The iodine market continues to be challenging, but the Company is pleased to be at low level inventory levels compared to other iodine producers. The Company had near record sales for the month which demonstrates good demand for our products. The Company will continue to manage this process as IO#5 and IO#6 production come online in coming months."

 

For further information, please contact:

 

Jeff Ploen, Interim CEO and President

Iofina

Tel: +44 (0)20 3006 3135

 

John Prior/Rupert Krefting/Huw Jeremy

Numis Securities

Tel: +44 (0)20 7260 1000

 

Rob Collins/Emily Morris/Liz Williamson

GMP Securities

Tel: +44(0)20 7647 2800

 

Media Contact:

Dominic Barretto/Anna Legge

Yellow Jersey PR

Tel: +44 (0)7768 537 739

 

About Iofina:

 

Iofina specializes in the exploration and production of iodine, iodine specialty chemical derivatives and produced water. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb™ technology. Iofina has production operations in the United States, specifically in Texas, Montana, Kentucky and Oklahoma. It has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end-products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes in Europe, North America and Asia. Iofina utilises its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

www.iofina.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFLDRVIFIIS
Date   Source Headline
2nd May 20247:00 amRNSFinal Results
16th Apr 20247:00 amRNSQ1 2024 Corporate Update
17th Jan 20247:00 amRNSHolding(s) in Company
15th Jan 20247:00 amRNSQ4 2023 Corporate Update
30th Nov 20237:00 amRNSIO#9 Update
20th Oct 20237:00 amRNSSigned Agreement for IO#10 and Q3 2023 Update
11th Sep 20237:00 amRNSInterim Results
25th Aug 20235:00 pmRNSHolding(s) in Company
24th Jul 20235:00 pmRNSHolding(s) in Company
20th Jul 20237:00 amRNSH1 Update and Updated Loan Facilities
14th Jun 20232:00 pmRNSResult of AGM
14th Jun 20237:00 amRNSIO#9 Iodine Plant Operating
9th May 20237:00 amRNSNotice of AGM
4th May 20237:00 amRNSInvestor Presentation
28th Apr 20234:45 pmRNSHolding(s) in Company
28th Apr 20237:00 amRNSGrant of Share Options
25th Apr 20237:00 amRNS2022 FULL YEAR RESULTS
12th Apr 20237:00 amRNSProduction Update
20th Feb 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Update
9th Jan 20237:00 amRNSMarket Update
28th Dec 20222:34 pmRNSHolding(s) in Company
14th Dec 20227:00 amRNSIofina Chemical Awarded ISO Certification
21st Nov 20227:00 amRNSChange of Adviser
28th Oct 20227:00 amRNSFinalised Terms for IO9 & Q3 Production Update
26th Sep 202211:06 amRNSSecond Price Monitoring Extn
26th Sep 202211:00 amRNSPrice Monitoring Extension
26th Sep 20227:00 amRNSInterim Results
8th Jul 20227:00 amRNSAdditional Loan Facilities and H1 Update
5th Jul 20228:54 amRNSHolding(s) in Company
22nd Jun 20222:30 pmRNSResult of AGM
20th Jun 20227:00 amRNSAppointment of Chrystal Capital Partners LLP
27th May 20227:00 amRNSNotice of AGM
26th May 20224:15 pmRNSHolding(s) in Company
26th May 20222:15 pmRNSHolding(s) in Company
24th May 20226:15 pmRNSHolding(s) in Company
20th May 20227:10 amRNSInvestor Presentation
18th May 20227:00 amRNSHolding(s) in Company
9th May 20227:00 amRNSFinal Results
5th May 20227:00 amRNSHolding(s) in Company
28th Apr 20228:38 amRNSHolding(s) in Company
19th Apr 20227:00 amRNSQ1 2022 and IO#9 Update
8th Apr 20221:07 pmRNSHolding(s) in Company
17th Mar 20227:00 amRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSHolding(s) in Company
14th Mar 20227:00 amRNSDirector/PDMR Shareholding
11th Mar 20227:00 amRNSDirector/PDMR Shareholding
10th Mar 20227:00 amRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSGrant of Share Options
8th Mar 20228:51 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.